Product Name | Ibrexafungerp Citrate - API |
Product Code | DA-I140-a |
Chemical name | Ibrexafungerp Citrate |
Synonyms | SCY 078 Citrate; MK-3118; 4H-1,4a-Propano-2H-phenanthro[1,2-c]pyran-7-carboxylic acid, 15-[(2R)-2-amino-2,3,3-trimethylbutoxy]-8-[(1R)-1,2-dimethylpropyl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-14-[5-(4-pyridinyl)-1H-1,2,4-triazol-1-yl]-, (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); (1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-Amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid compound with 2-hydroxypropane-1,2,3-tricarboxylic acid (1:1); |
Impurity | NA |
CAS Number | 1965291-08-0 |
Alternate CAS # | NA |
Molecular form | C50H75N5O11 |
Appearance | NA |
Melting Point | NA |
Mol. Weight | 922.17 |
Storage | 2-8°C Refrigerator |
Solubility | NA |
Stability | NA |
Category | pharmaceutical standards,intermediates,Fine Chemicals |
Boiling Point | NA |
Applications | Ibrexafungerp, also known as SCY-078 or MK-3118, is a novel enfumafungin derivative oral triterpene antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as a vaginal yeast infection.It was developed out of a need to treat fungal infections that may have become resistant to echinocandins or azole antifungals. |
Dangerous Goods Info | NA |
References | NA |
Extra Notes | NA |
Documents (MSDS) | No Data Available |
Keywords | NA |